PRF Technologies (PRFX) Depreciation & Amortization (CF) (2021 - 2024)
PRF Technologies (PRFX) posted quarterly Depreciation & Amortization (CF) of $4000.0 for Q1 2024, up 100.0% year-on-year from $2000.0 in Q2 2023, and down 33.33% on a QoQ basis from $6000.0 in Q4 2023.
PRF Technologies (PRFX) Depreciation & Amortization (CF) (2021 - 2024) Analysis & Trends
PRF Technologies (PRFX) has reported Depreciation & Amortization (CF) for 4 consecutive years, with $4000.0 the latest figure, recorded in Q1 2024.
- Quarterly Depreciation & Amortization (CF) rose 100.0% year-over-year to $4000.0 in Q1 2024, while the trailing twelve-month figure through Jun 2025 was $4000.0 (down 69.23% YoY) and the FY2025 annual result came in at $15000.0, down 6.25% from the prior year.
- Depreciation & Amortization (CF) eased to $4000.0 in Q1 2024 per PRFX's latest filing, from $6000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for PRFX reached as high as $7000.0 in Q3 2022 and fell as low as $1000.0 in Q1 2021.
- A 4-year average of $3416.7 and a median of $3000.0 in 2021 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 250.0% — and 2023, when it tumbled 57.14%.
- Year by year, Depreciation & Amortization (CF) stood at $3000.0 in 2021, then surged by 100.0% to $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then sank by 33.33% to $4000.0 in 2024.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $4000.0, $6000.0, and $3000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |